|
|
|
|
LEADER |
01000caa a22002652 4500 |
001 |
ELV041201450 |
003 |
DE-627 |
005 |
20230624083232.0 |
007 |
cr uuu---uuuuu |
008 |
180726s2017 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1016/j.jpolmod.2017.07.005
|2 doi
|
028 |
5 |
2 |
|a GBV00000000000045A.pica
|
035 |
|
|
|a (DE-627)ELV041201450
|
035 |
|
|
|a (ELSEVIER)S0161-8938(17)30085-6
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
082 |
0 |
|
|a 340
|
082 |
0 |
4 |
|a 340
|q DE-600
|
082 |
0 |
4 |
|a 610
|q VZ
|
082 |
0 |
4 |
|a 610
|q VZ
|
084 |
|
|
|a 44.44
|2 bkl
|
100 |
1 |
|
|a Atashbar, Tohid
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Health reform policy-making: Fiscal sustainability matters (The case of Iran’s PresidentCare)
|
264 |
|
1 |
|c 2017
|
300 |
|
|
|a 16
|
336 |
|
|
|a nicht spezifiziert
|b zzz
|2 rdacontent
|
337 |
|
|
|a nicht spezifiziert
|b z
|2 rdamedia
|
338 |
|
|
|a nicht spezifiziert
|b zu
|2 rdacarrier
|
520 |
|
|
|a The government of Iran has implemented a major health system reform program, called the Health Reform Plan (HRP). HRP covers a wide range of structural, policy, pricing, and tariff reforms in a wide range of health promotion programs, including reducing the share of payment made by patients hospitalizing in public hospitals, promoting natural childbirth, supporting the retention of physicians in underserved areas, and providing financial protection for incurable or needy patients.
|
650 |
|
7 |
|a C53
|2 Elsevier
|
650 |
|
7 |
|a I18
|2 Elsevier
|
650 |
|
7 |
|a H51
|2 Elsevier
|
650 |
|
7 |
|a H75
|2 Elsevier
|
650 |
|
7 |
|a P41
|2 Elsevier
|
650 |
|
7 |
|a C51
|2 Elsevier
|
650 |
|
7 |
|a H39
|2 Elsevier
|
700 |
1 |
|
|a Arani, Abbas Assari
|4 oth
|
700 |
1 |
|
|a Antoun, Joseph
|4 oth
|
700 |
1 |
|
|a Bossert, Thomas
|4 oth
|
773 |
0 |
8 |
|i Enthalten in
|n Elsevier
|a Lupberger, J. ELSEVIER
|t 369 EGFR SIGNALING IMPAIRS THE ANTIVIRAL ACTIVITY OF INTERFERON-ALPHA
|d 2013
|d JPMOD : a social science forum of world issues
|g Amsterdam [u.a.]
|w (DE-627)ELV016667247
|
773 |
1 |
8 |
|g volume:39
|g year:2017
|g number:6
|g pages:1086-1101
|g extent:16
|
856 |
4 |
0 |
|u https://doi.org/10.1016/j.jpolmod.2017.07.005
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_U
|
912 |
|
|
|a GBV_ELV
|
912 |
|
|
|a SYSFLAG_U
|
912 |
|
|
|a SSG-OLC-PHA
|
912 |
|
|
|a GBV_ILN_21
|
912 |
|
|
|a GBV_ILN_70
|
912 |
|
|
|a GBV_ILN_350
|
912 |
|
|
|a GBV_ILN_2003
|
912 |
|
|
|a GBV_ILN_2006
|
912 |
|
|
|a GBV_ILN_2008
|
912 |
|
|
|a GBV_ILN_2060
|
912 |
|
|
|a GBV_ILN_2470
|
936 |
b |
k |
|a 44.44
|j Parasitologie
|x Medizin
|q VZ
|
951 |
|
|
|a AR
|
952 |
|
|
|d 39
|j 2017
|e 6
|h 1086-1101
|g 16
|
953 |
|
|
|2 045F
|a 340
|